Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
Sanofi-Aventis Australia
Administration route
Intramuscular injection
Subcutaneous injection
Vaccine group
All people aged ≥6 months
Description:
Registered for use in people aged ≥6 months.
Trivalent inactivated influenza vaccine, split virion.
Each 0.5 mL monodose pre-filled syringe contains:
- 15 µg haemagglutinin of each of the 3 recommended influenza virus strains
May contain traces of:
- ovalbumin (≤ 0.05 µg)
- neomycin (≤ 10.1 pg)
- formaldehyde (≤ 30 µg)
- octoxinol-9 (≤ 222.5 µg)
For Product Information and Consumer Medicine Information about Vaxigrip visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Page history
Last updated
Last reviewed
Related diseases